Showing results (241-250 of 260) with videos related to
Sort By:
Pageof 26
Lancet (London, England)|March 16, 2004
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trialsWerner Hacke, Geoffrey Donnan, Cesare Fieschi, et al.Parkinsonism & Related Disorders|June 25, 2013
The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's diseaseCarmen Rodriguez-Blazquez, Jose Manuel Rojo-Abuin, Mario Alvarez-Sanchez, et al.Movement Disorders Clinical Practice|October 21, 2014
Official Japanese Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale: validation against the original English versionKenichi Kashihara, Tomoyoshi Kondo, Yoshikuni Mizuno, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 23, 2006
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing planChristopher G Goetz, Stanley Fahn, Pablo Martinez-Martin, et al.JAMA|July 25, 2014
Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trialClaudia S Robertson, H Julia Hannay, José-Miguel Yamal, et al.Journal of Parkinson'S Disease|December 3, 2016
Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1Robert A Hauser, Ruosha Li, Adriana Pérez, et al.JMIR Research Protocols|April 17, 2019
Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161)Anne M Neilan, Kunjal Patel, Allison L Agwu, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2008
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing resultsChristopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, et al.Stroke|April 11, 2015
Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III TrialYuko Y Palesch, Sharon D Yeatts, Thomas A Tomsick, et al.Lancet (London, England)|May 18, 2010
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsKennedy R Lees, Erich Bluhmki, Rüdiger von Kummer, et al.Pageof 26